Search research articles
Contact Us
Filters
Showing results (1-10 of 29) with videos related to
Page
of 3
Sort By:
Expert Opinion on Drug Discovery
|
March 16, 2013
Effect of lipid-modifying therapies on the functional quality of high-density lipoproteins: implications for drug development
Myngan Duong, Stephen J Nicholls
Current Medicinal Chemistry
|
April 17, 2014
New drugs for HDL-C disorders: the beginning
MyNgan Duong, Stephen J Nicholls
Current Vascular Pharmacology
|
May 1, 2013
Controversies on HDL: should it be a target biomarker in patients with lipid disorders?
Stephen J Nicholls, Jordan Andrews, MyNgan Duong
Current Cardiology Reports
|
March 23, 2016
CETP Inhibition in CVD Prevention: an Actual Appraisal
Belinda Di Bartolo, Kohei Takata, MyNgan Duong, et al.
Current Opinion in Lipidology
|
September 28, 2016
Clinical trials with cholesteryl ester transfer protein inhibitors
Belinda A Di Bartolo, MyNgan Duong, Stephen J Nicholls
Current Opinion in Lipidology
|
September 19, 2015
Acute high-density lipoprotein therapies
MyNgan Duong, Belinda A Di Bartolo, Stephen J Nicholls
Journal of Lipid Research
|
December 6, 2005
Measurement of cholesterol bidirectional flux between cells and lipoproteins
Francesca Zimetti, Ginny K Weibel, Myngan Duong, et al.
Expert Opinion on Drug Discovery
|
April 4, 2012
The emerging role of plasma lipidomics in cardiovascular drug discovery
Rishi Puri, MyNgan Duong, Kiyoko Uno, et al.
Plos One
|
September 15, 2018
Induction of obesity impairs reverse cholesterol transport in ob/ob mice
MyNgan Duong, Kiyoko Uno, Victoria Nankivell, et al.
Journal of Clinical Medicine
|
November 26, 2022
The Association of Sex with Unplanned Cardiac Readmissions following Percutaneous Coronary Intervention in Australia: Results from a Multicentre Outcomes Registry (GenesisCare Cardiovascular Outcomes Registry)
Andre Conradie, John Atherton, Enayet Chowdhury, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 29) with videos related to
Sort By:
Page
of 3
Expert Opinion on Drug Discovery
|
March 16, 2013
Effect of lipid-modifying therapies on the functional quality of high-density lipoproteins: implications for drug development
Myngan Duong, Stephen J Nicholls
Current Medicinal Chemistry
|
April 17, 2014
New drugs for HDL-C disorders: the beginning
MyNgan Duong, Stephen J Nicholls
Current Vascular Pharmacology
|
May 1, 2013
Controversies on HDL: should it be a target biomarker in patients with lipid disorders?
Stephen J Nicholls, Jordan Andrews, MyNgan Duong
Current Cardiology Reports
|
March 23, 2016
CETP Inhibition in CVD Prevention: an Actual Appraisal
Belinda Di Bartolo, Kohei Takata, MyNgan Duong, et al.
Current Opinion in Lipidology
|
September 28, 2016
Clinical trials with cholesteryl ester transfer protein inhibitors
Belinda A Di Bartolo, MyNgan Duong, Stephen J Nicholls
Current Opinion in Lipidology
|
September 19, 2015
Acute high-density lipoprotein therapies
MyNgan Duong, Belinda A Di Bartolo, Stephen J Nicholls
Journal of Lipid Research
|
December 6, 2005
Measurement of cholesterol bidirectional flux between cells and lipoproteins
Francesca Zimetti, Ginny K Weibel, Myngan Duong, et al.
Expert Opinion on Drug Discovery
|
April 4, 2012
The emerging role of plasma lipidomics in cardiovascular drug discovery
Rishi Puri, MyNgan Duong, Kiyoko Uno, et al.
Plos One
|
September 15, 2018
Induction of obesity impairs reverse cholesterol transport in ob/ob mice
MyNgan Duong, Kiyoko Uno, Victoria Nankivell, et al.
Journal of Clinical Medicine
|
November 26, 2022
The Association of Sex with Unplanned Cardiac Readmissions following Percutaneous Coronary Intervention in Australia: Results from a Multicentre Outcomes Registry (GenesisCare Cardiovascular Outcomes Registry)
Andre Conradie, John Atherton, Enayet Chowdhury, et al.
Page
of 3